Beta-blockers no better than placebo in the treatment of vasovagal syncope.
Phillips
John
J
Virginia Commonwealth University, Fairfax Family Practice Residency, Fairfax, VA, USA.
Krist
Alex
A
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000328:Adult; D000368:Aged; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009248:Nadolol / Q000008:administration & dosage*; D011336:Probability; D011379:Prognosis; D011433:Propranolol / Q000008:administration & dosage*; D011446:Prospective Studies; D012016:Reference Values; D012720:Severity of Illness Index; D019462:Syncope, Vasovagal / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D009248:Nadolol; D011433:Propranolol